SCHEMBL10690019

SCHEMBL10690019

CN1C2CCNCC1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL929913 0.83 LMNA (0.37)
SCHEMBL31208706 0.83 HTR6 (0.38)
SCHEMBL26322407 0.82
SCHEMBL14410723 0.82
SCHEMBL12564432 0.82
Hydrochloric Acid SCHEMBL14880059 0.81 LMNA (0.36)
Hydrochloric Acid SCHEMBL30900303 0.79 LMNA (0.36)
SCHEMBL2292002 0.79 HTR6 (0.42)
SCHEMBL31208679 0.76 HTR6 (0.39)
SCHEMBL31209248 0.74 HTR6 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152238-A1 PHARMACEUTICAL COMPOUNDS NEUROSCIENZE PHARMANESS S.C. A.R.L. (IT) 2011-06-23 US disclosed
US-4775668-A Substituted bridged-diazabicycloalkyl quinolone carboxylic acids and anti-bacterial use thereof PFIZER INC. (US) 1988-10-04 US disclosed